资讯

Yahoo Finance

Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study

SAN DIEGO, July 16, 2025--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation to ...
Business Wire

Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients

SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained ...
Business Wire

Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of ...

SAN DIEGO--(BUSINESS WIRE)--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained ...
Mena FN

Verse By Verse Ministry International Releases Full Spanish Translation Of Revelation Bible ...

(MENAFN- EIN Presswire) The Only Free, In-Depth Expository Revelation Study-Now Accessible to Spanish Speakers Worldwide San Antonio, TX – Verse By Verse Ministry International (VBVMI) is pleased to ...